TickerLeague

EPS (Diluted) for Revolution Medicines (RVMD)

According to Revolution Medicines's latest reported financial statements, the company's current diluted EPS (TTM) is $-7.11. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$-7.11

YoY change

+66.2%

5Y CAGR

N/A

Peak year (2017)

$-0.85

Latest annual

$-5.95

EPS (Diluted) history chart for Revolution Medicines (RVMD) from 2017 to 2025

EPS (Diluted) history table for Revolution Medicines (RVMD) from 2017 to 2025

Fiscal yearPeriod endedReportedEPS (Diluted)YoYYoY change
2025$-5.95+66.2%$-2.37
2024$-3.58-7.3%+$0.28
2023$-3.86+25.3%$-0.78
2022$-3.08+24.7%$-0.61
2021$-2.47+52.5%$-0.85
2020$-1.62+23.7%$-0.31
2019$-1.31+13.9%$-0.16
2018$-1.15+35.3%$-0.30
2017$-0.85

EPS (Diluted) values are taken from Revolution Medicines's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual diluted EPS for Revolution Medicines (RVMD) came in at $-5.95 – surged 66.2% year-over-year.

The dataset's maximum diluted EPS sits at $-0.85 (2017); the minimum reading of $-5.95 dates to 2025.

Among 8 Healthcare peers, Revolution Medicines (RVMD) ranks 9th; the peer median for diluted EPS is $12.13.

Revolution Medicines EPS (Diluted) by Year

Revolution Medicines EPS (Diluted) 2025: $-5.95

Revolution Medicines diluted EPS in 2025 was $-5.95, surged 66.2% from 2024. This figure represents the lowest annual value in the available history.

Revolution Medicines EPS (Diluted) 2024: $-3.58

Revolution Medicines diluted EPS in 2024 was $-3.58, declined 7.3% below 2023.

Revolution Medicines EPS (Diluted) 2023: $-3.86

Revolution Medicines diluted EPS in 2023 was $-3.86, grew 25.3% from 2022.

Revolution Medicines EPS (Diluted) 2022: $-3.08

Revolution Medicines diluted EPS in 2022 was $-3.08, grew 24.7% from 2021.

Revolution Medicines EPS (Diluted) 2021: $-2.47

Revolution Medicines diluted EPS in 2021 was $-2.47.

See more financial history for Revolution Medicines (RVMD).

Sector peers — EPS (Diluted)

Companies in the same sector as Revolution Medicines, ranked by their latest diluted EPS.

CompanyEPS (Diluted)Sector
Novo Nordisk (NVO)$23.03Healthcare
Eli Lilly (LLY)$22.95Healthcare
Amgen (AMGN)$14.23Healthcare
UnitedHealth Group (UNH)$13.23Healthcare
Johnson & Johnson (JNJ)$11.03Healthcare
Merck & Co. (MRK)$7.28Healthcare
AstraZeneca (AZN)$6.54Healthcare
AbbVie (ABBV)$2.37Healthcare

Frequently asked questions

What is Revolution Medicines's diluted EPS?

Latest reported diluted EPS for Revolution Medicines (RVMD) is $-7.11 (period ending March 31, 2026).

How has Revolution Medicines diluted EPS changed year-over-year?

Revolution Medicines (RVMD) diluted EPS changed +66.2% year-over-year on the latest annual filing.

When did Revolution Medicines diluted EPS hit its highest annual value?

Revolution Medicines diluted EPS reached its highest annual value of $-0.85 in 2017.

What was Revolution Medicines diluted EPS in 2024?

Revolution Medicines (RVMD) diluted EPS in 2024 was $-3.58.

What was Revolution Medicines diluted EPS in 2025?

Revolution Medicines (RVMD) diluted EPS in 2025 was $-5.95.

RVMD Key Financials

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.